Free Trial

Y Intercept Hong Kong Ltd Trims Stock Position in Perrigo Company plc (NYSE:PRGO)

Perrigo logo with Medical background

Y Intercept Hong Kong Ltd decreased its position in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 83.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,791 shares of the company's stock after selling 100,727 shares during the quarter. Y Intercept Hong Kong Ltd's holdings in Perrigo were worth $519,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. MML Investors Services LLC increased its stake in shares of Perrigo by 7.7% in the 3rd quarter. MML Investors Services LLC now owns 39,174 shares of the company's stock valued at $1,028,000 after purchasing an additional 2,811 shares in the last quarter. XTX Topco Ltd increased its position in shares of Perrigo by 536.9% in the third quarter. XTX Topco Ltd now owns 62,509 shares of the company's stock valued at $1,640,000 after buying an additional 52,695 shares in the last quarter. Wellington Management Group LLP lifted its position in shares of Perrigo by 229.2% during the 3rd quarter. Wellington Management Group LLP now owns 2,697,698 shares of the company's stock valued at $70,761,000 after buying an additional 1,878,145 shares in the last quarter. Stifel Financial Corp increased its holdings in Perrigo by 11.0% in the 3rd quarter. Stifel Financial Corp now owns 133,278 shares of the company's stock worth $3,496,000 after acquiring an additional 13,249 shares in the last quarter. Finally, Systematic Financial Management LP increased its holdings in Perrigo by 10.3% in the 3rd quarter. Systematic Financial Management LP now owns 1,252,653 shares of the company's stock worth $32,857,000 after acquiring an additional 116,832 shares in the last quarter. 95.91% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Perrigo

In other Perrigo news, Director Jeffrey B. Kindler sold 17,598 shares of the firm's stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $28.27, for a total value of $497,495.46. Following the completion of the transaction, the director now owns 5,409 shares of the company's stock, valued at $152,912.43. This trade represents a 76.49 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 0.70% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

PRGO has been the topic of several research analyst reports. Jefferies Financial Group reiterated a "hold" rating and issued a $30.00 target price (down previously from $50.00) on shares of Perrigo in a research report on Monday, September 23rd. Canaccord Genuity Group reiterated a "buy" rating and set a $42.00 price objective on shares of Perrigo in a research note on Monday, September 30th. Finally, StockNews.com raised Perrigo from a "hold" rating to a "buy" rating in a research note on Thursday, November 7th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, Perrigo currently has a consensus rating of "Moderate Buy" and an average target price of $37.00.

Check Out Our Latest Report on Perrigo

Perrigo Trading Down 2.8 %

NYSE PRGO traded down $0.76 on Monday, reaching $26.69. 1,423,798 shares of the company were exchanged, compared to its average volume of 1,600,509. Perrigo Company plc has a fifty-two week low of $23.89 and a fifty-two week high of $34.60. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94. The business's fifty day moving average price is $26.57 and its 200 day moving average price is $26.96. The stock has a market capitalization of $3.64 billion, a P/E ratio of -22.81 and a beta of 0.52.

Perrigo (NYSE:PRGO - Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.81 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.81. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The business had revenue of $1.09 billion during the quarter, compared to the consensus estimate of $1.12 billion. During the same quarter last year, the firm earned $0.64 EPS. The business's revenue was down 3.2% compared to the same quarter last year. Analysts forecast that Perrigo Company plc will post 2.56 earnings per share for the current year.

Perrigo Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Friday, November 29th will be issued a $0.276 dividend. The ex-dividend date of this dividend is Friday, November 29th. This represents a $1.10 annualized dividend and a yield of 4.14%. Perrigo's dividend payout ratio (DPR) is currently -94.02%.

Perrigo Profile

(Free Report)

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

Recommended Stories

Institutional Ownership by Quarter for Perrigo (NYSE:PRGO)

Should you invest $1,000 in Perrigo right now?

Before you consider Perrigo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.

While Perrigo currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Massive Market Moves Following Trump Win: Tesla, JP Morgan, & Bitcoin Soar

Massive Market Moves Following Trump Win: Tesla, JP Morgan, & Bitcoin Soar

MarketBeat analyst Thomas Hughes breaks down the biggest winners of the day, including Tesla, JP Morgan, and the Russell 2000, and why they’re surging.

Recent Videos

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?
SoundHound Stock Explodes Again – Is a Major Breakout Coming?
How Fintech Strategy at FinWise Bancorp and CEO Vision Are Driving 78% Gains

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines